Navigation Links
Chesley Files Class Action Against DePuy Orthopaedics
Date:11/4/2010

CINCINNATI, Nov. 4, 2010 /PRNewswire/ -- Stanley M. Chesley of the Cincinnati, Ohio-based law firm of Waite, Schneider, Bayless & Chesley Co., L.P.A. earlier today filed a major class action lawsuit against DePuy Orthopaedics, Inc. and Johnson and Johnson (NYSE: JNJ).

DePuy and Johnson and Johnson recently recalled over 90,000 ASR XL Acetabular hip replacement Systems. The system has an unacceptable failure rate causing patients to undergo hip replacement surgery.

DePuy and Johnson and Johnson notified Chesley's client Carolyn Pearcy that she has a recalled ASR XL Acetabular hip system and advised her, similar to other recipients, to undergo a series of tests. Pearcy believes that her recalled hip was the probable cause of her persistent and excruciating pain.

In her action Pearcy seeks court supervised medical monitoring. The goal is to ensure that every recipient receives without cost necessary medical tests. According to Chesley, "DePuy refuses to accept fundamental financial responsibility. It wants patients and their insurance companies to pay for medical tests required because of DePuy's bad hips."

Pearcy also is seeking damages including punitive damages. Chesley commented that "DePuy and J&J were on notice of the defective system, yet continued to manufacture, market and sell it to innocent victims."

For more than 40 years, Stanley M. Chesley and Waite, Schneider, Bayless & Chesley Co., L.P.A. have represented individuals from across the United States in a variety of personal injury, breach of contract, fraud, and negligence claims, including complex product liability cases, toxic exposure, and dangerous prescription drugs.  More information on the firm is found at http://www.wsbclaw.com.

CONTACT:   Stanley M. Chesley or Terrence L. Goodman at (513) 621-0267


'/>"/>
SOURCE Stanley Chesley of Waite, Schneider, Bayless & Chesley Co., L.P.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Chesley Files Federal Zicam Lawsuits
2. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
3. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
4. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
5. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
6. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
7. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
8. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
9. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
10. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
11. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):